China Resources Boya Bio pharmaceutical Group Co Ltd (300294) — Cash Flow Quality Index
China Resources Boya Bio pharmaceutical Group Co Ltd (300294) has a Cash Flow Quality Index of 0.37x as of September 2025. Operating cash flow of CN¥43.70 Million is below net income of CN¥117.62 Million, suggesting accrual-heavy earnings not yet converted to cash. Explore long-term investment intensity of China Resources Boya Bio pharmaceutical to see how much of total assets are deployed in long-term investments.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
China Resources Boya Bio pharmaceutical Group Co Ltd Cash Flow Quality Index (2009–2025)
Historical Cash Flow Quality Index for China Resources Boya Bio pharmaceutical Group Co Ltd across 17 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check 300294 tangible net assets ratio to evaluate the tangible quality of the company's equity base.
Annual Cash Flow Quality Index for China Resources Boya Bio pharmaceutical Group Co Ltd (2009–2025)
Year-by-year earnings quality comparison for China Resources Boya Bio pharmaceutical Group Co Ltd. For live market cap and the full company financial profile, see China Resources Boya Bio pharmaceutical market capitalisation.
| Year | Quality Index | Operating CF (CNY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 1.04x | CN¥116.69 Million | CN¥112.70 Million | ▲ +37.1% |
| 2024 | 0.76x | CN¥299.78 Million | CN¥396.99 Million | ▼ -72.1% |
| 2023 | 2.70x | CN¥641.73 Million | CN¥237.47 Million | ▲ +101.8% |
| 2022 | 1.34x | CN¥596.44 Million | CN¥445.49 Million | ▼ -64.3% |
| 2021 | 3.76x | CN¥1.35 Billion | CN¥358.28 Million | ▲ +43.8% |
| 2020 | 2.61x | CN¥718.58 Million | CN¥275.26 Million | ▲ +1107.9% |
| 2019 | -0.26x | CN¥-114.51 Million | CN¥442.12 Million | ▼ -460.0% |
| 2018 | 0.07x | CN¥34.90 Million | CN¥485.08 Million | ▲ +210.3% |
| 2017 | -0.07x | CN¥-23.82 Million | CN¥364.93 Million | ▼ -109.1% |
| 2016 | 0.72x | CN¥198.76 Million | CN¥277.55 Million | ▼ -18.6% |
| 2015 | 0.88x | CN¥147.02 Million | CN¥167.05 Million | ▼ -16.8% |
| 2014 | 1.06x | CN¥121.88 Million | CN¥115.20 Million | ▼ -2.2% |
| 2013 | 1.08x | CN¥89.11 Million | CN¥82.36 Million | ▼ -12.0% |
| 2012 | 1.23x | CN¥92.36 Million | CN¥75.15 Million | ▼ -1.7% |
| 2011 | 1.25x | CN¥81.53 Million | CN¥65.23 Million | ▲ +152.2% |
| 2010 | 0.50x | CN¥24.77 Million | CN¥49.98 Million | ▼ -69.9% |
| 2009 | 1.65x | CN¥51.88 Million | CN¥31.51 Million | — |